| The effect of human mobility and control measures on the COVID-19 epidemic in China MUG Kraemer, CH Yang, B Gutierrez, CH Wu, B Klein, DM Pigott, ... Science 368 (6490), 493-497, 2020 | 3194 | 2020 |
| Pandemic potential of a strain of influenza A (H1N1): early findings C Fraser, CA Donnelly, S Cauchemez, WP Hanage, MD Van Kerkhove, ... science 324 (5934), 1557-1561, 2009 | 2570 | 2009 |
| eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data EJ Feil, BC Li, DM Aanensen, WP Hanage, BG Spratt Journal of bacteriology 186 (5), 1518-1530, 2004 | 2262 | 2004 |
| Persistence and evolution of SARS-CoV-2 in an immunocompromised host B Choi, MC Choudhary, J Regan, JA Sparks, RF Padera, X Qiu, ... New England Journal of Medicine 383 (23), 2291-2293, 2020 | 1252 | 2020 |
| Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications AT Levin, WP Hanage, N Owusu-Boaitey, KB Cochran, SP Walsh, ... European journal of epidemiology 35 (12), 1123-1138, 2020 | 1062 | 2020 |
| Rapid pneumococcal evolution in response to clinical interventions NJ Croucher, SR Harris, C Fraser, MA Quail, J Burton, M Van Der Linden, ... science 331 (6016), 430-434, 2011 | 1019 | 2011 |
| SARS-CoV-2 titers in wastewater are higher than expected from clinically confirmed cases F Wu, J Zhang, A Xiao, X Gu, WL Lee, F Armas, K Kauffman, W Hanage, ... Msystems 5 (4), 10.1128/msystems. 00614-20, 2020 | 857 | 2020 |
| Antibiotics in agriculture and the risk to human health: how worried should we be? Q Chang, W Wang, G Regev‐Yochay, M Lipsitch, WP Hanage Evolutionary applications 8 (3), 240-247, 2015 | 753 | 2015 |
| Recombination and the nature of bacterial speciation C Fraser, WP Hanage, BG Spratt Science 315 (5811), 476-480, 2007 | 612 | 2007 |
| Horizontal gene transfer and adaptive evolution in bacteria BJ Arnold, IT Huang, WP Hanage Nature Reviews Microbiology 20 (4), 206-218, 2022 | 557 | 2022 |
| An omics-based framework for assessing the health risk of antimicrobial resistance genes AN Zhang, JM Gaston, CL Dai, S Zhao, M Poyet, M Groussin, X Yin, LG Li, ... Nature communications 12 (1), 4765, 2021 | 527 | 2021 |
| The bacterial species challenge: making sense of genetic and ecological diversity C Fraser, EJ Alm, MF Polz, BG Spratt, WP Hanage science 323 (5915), 741-746, 2009 | 511 | 2009 |
| Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis C Fraser, TD Hollingsworth, R Chapman, F de Wolf, WP Hanage Proceedings of the National Academy of Sciences 104 (44), 17441-17446, 2007 | 509 | 2007 |
| Horizontal gene transfer and the evolution of bacterial and archaeal population structure MF Polz, EJ Alm, WP Hanage Trends in Genetics 29 (3), 170-175, 2013 | 459 | 2013 |
| Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine SI Pelton, H Huot, JA Finkelstein, CJ Bishop, KK Hsu, J Kellenberg, ... The Pediatric infectious disease journal 26 (6), 468-472, 2007 | 451 | 2007 |
| Making sense of mutation: what D614G means for the COVID-19 pandemic remains unclear ND Grubaugh, WP Hanage, AL Rasmussen Cell 182 (4), 794-795, 2020 | 435 | 2020 |
| Fuzzy species among recombinogenic bacteria WP Hanage, C Fraser, BG Spratt BMC biology 3, 1-7, 2005 | 427 | 2005 |
| Population genomics of post-vaccine changes in pneumococcal epidemiology NJ Croucher, JA Finkelstein, SI Pelton, PK Mitchell, GM Lee, J Parkhill, ... Nature genetics 45 (6), 656-663, 2013 | 408 | 2013 |
| Genomic epidemiology of the Escherichia coli O104: H4 outbreaks in Europe, 2011 YH Grad, M Lipsitch, M Feldgarden, HM Arachchi, GC Cerqueira, ... Proceedings of the national academy of sciences 109 (8), 3065-3070, 2012 | 373 | 2012 |
| Scientific consensus on the COVID-19 pandemic: we need to act now NA Alwan, RA Burgess, S Ashworth, R Beale, N Bhadelia, D Bogaert, ... The Lancet 396 (10260), e71-e72, 2020 | 351 | 2020 |
Marc LipsitchDepartment of Epidemiology, Harvard School of Public Health在 hsph.harvard.edu 的電子郵件地址已通過驗證
Stephen BentleyWellcome Sanger Institute在 sanger.ac.uk 的電子郵件地址已通過驗證
Christophe FraserPandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford在 ndm.ox.ac.uk 的電子郵件地址已通過驗證
Brian G SprattImperial College London, Emeritus Professor在 imperial.ac.uk 的電子郵件地址已通過驗證
Nick CroucherImperial College在 imperial.ac.uk 的電子郵件地址已通過驗證
Jukka CoranderUiO, Wellcome Sanger Institute, University of Helsinki在 medisin.uio.no 的電子郵件地址已通過驗證
Julian ParkhillUniversity of Cambridge在 cam.ac.uk 的電子郵件地址已通過驗證
E J FeilProfessor of Microbial Evolution在 bath.ac.uk 的電子郵件地址已通過驗證Eric AlmProfessor of Biological Engineering, MIT在 mit.edu 的電子郵件地址已通過驗證
Simon R. HarrisSenior Program Officer, Bill & Melinda Gates Foundation在 sanger.ac.uk 的電子郵件地址已通過驗證
Yonatan GradProfessor of Immunology and Infectious Diseases, Harvard TH Chan School of Public Health在 hsph.harvard.edu 的電子郵件地址已通過驗證
Brian J ArnoldPrinceton University在 princeton.edu 的電子郵件地址已通過驗證
Karel BřindaInria Starting Faculty, Inria/IRISA Rennes在 inria.fr 的電子郵件地址已通過驗證
Alessandro VespignaniSternberg Family Distinguished Professor, Northeastern University, Boston在 neu.edu 的電子郵件地址已通過驗證
Moritz U G KraemerProfessor, University of Oxford在 biology.ox.ac.uk 的電子郵件地址已通過驗證
Ken KleinmanUniversity of Massachusetts, Amherst在 umass.edu 的電子郵件地址已通過驗證
